Drug Landscape ›
Tadalafil 5mg ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 26
Most-reported reactions
Dizziness — 4 reports (15.38%) Drug Ineffective — 4 reports (15.38%) Headache — 3 reports (11.54%) Off Label Use — 3 reports (11.54%) Condition Aggravated — 2 reports (7.69%) Dysuria — 2 reports (7.69%) Micturition Urgency — 2 reports (7.69%) Nausea — 2 reports (7.69%) Pain In Extremity — 2 reports (7.69%) Product Substitution Issue — 2 reports (7.69%)
Source database →
Tadalafil 5mg in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Tadalafil 5mg approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Tadalafil 5mg in United States?
Aswan University is the originator. The local marketing authorisation holder may differ — check the official source linked above.